US FDA Approves Novo's Weekly Insulin Awiqli for Children
Novo’s Awiqli has received US FDA approval as the first and only once-weekly insulin for children aged 10 years and older with Type 2 Diabetes.
Michael Radin | 24/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy